Home › Funds › J.H. Whitney Equity Partners VII, LLC › AVAH

J.H. Whitney Equity Partners VII, LLC position in AVAH

AVEANNA HEALTHCARE HLDGS INC · Health Care

J.H. Whitney Equity Partners VII, LLC reported holding 1,036,300 shares of AVAH (AVEANNA HEALTHCARE HLDGS INC) in its Q3 2026 13F filing — a position valued at US$12.9M, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. J.H. Whitney Equity Partners VII, LLC has disclosed AVAH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.04M sh
Reported value held$12.86M
Portfolio Weight100.00%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How J.H. Whitney Equity Partners VII, LLC's AVAH position evolved

J.H. Whitney Equity Partners VII, LLC first disclosed a stake in AVAH in Q3 2023 at 48,655,882 shares (US$57.9M). The position peaked in Q3 2025 at 45,840,599 shares, worth US$406.6M. Across 13 filings, J.H. Whitney Equity Partners VII, LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 1,036,300 shares valued at US$12.9M — a reduction of -26,025,667 shares quarter over quarter.. Notable position changes include a 25% trim in Q2 2026 (shares rose 45% over the following quarter), a 96% trim in Q3 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 48.66M $57.90M New
Q4 2023 48.66M $130.40M Hold
Q1 2024 48.66M $121.15M Hold
Q2 2024 48.66M $134.29M Hold
Q3 2024 48.66M $253.01M Hold
Q4 2024 48.66M $222.36M Hold
Q1 2025 48.52M $262.99M Hold
Q2 2025 45.92M $240.17M Reduce
Q3 2025 45.84M $406.61M Hold
Q4 2025 36.24M $296.10M Reduce
Q1 2026 36.24M $233.40M Hold
Q2 2026 27.06M $231.92M Reduce
Q3 2026 1.04M $12.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVAH and 13F data

AVAH (AVEANNA HEALTHCARE HLDGS INC) is a Health Care company. 66 other funds we track also report a position in AVAH — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$699.3M), Nut Tree Capital Management, LP (US$110.7M), Ophir Asset Management Pty Ltd (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVAH

All AVAH fund holders →

FAQ

How long has J.H. Whitney Equity Partners VII, LLC held AVAH?

J.H. Whitney Equity Partners VII, LLC has disclosed AVAH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is J.H. Whitney Equity Partners VII, LLC's current position in AVAH?

As of Q3 2026, J.H. Whitney Equity Partners VII, LLC holds 1.04M shares of AVAH (AVEANNA HEALTHCARE HLDGS INC), valued at $12.86M, representing 100.00% of its reported portfolio and ranking #1.

Has J.H. Whitney Equity Partners VII, LLC been buying or selling AVAH?

In the latest 13F filing (Q3 2026), J.H. Whitney Equity Partners VII, LLC reduced its position in AVAH. The position peaked in Q3 2025 at 45.84M shares.

Which other funds hold AVAH?

Other major institutional holders of AVAH include BAIN CAPITAL INVESTORS LLC, Nut Tree Capital Management, LP, Ophir Asset Management Pty Ltd, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.